Proceedings: Using Stem Cell Therapies to Reestablish Osteogenic Capability for Bone Regeneration.
The California Institute for Regenerative Medicine (CIRM) has invested approximately $70 million in programs targeting various orthopedic indications, including osteoporosis, bone fracture healing, vertebral compression fractures, and several others. The present article serves to outline the current state of CIRM's more advanced programs, comparing and contrasting them with the current standard of care and several other novel approaches under development.


CONCLUSIONS
This report describes CIRM bone programs that are in contrast to current cell therapy approaches. These projects aim to enhance stem cell activity for bone regeneration.
California Institute for Regenerative Medicine, San Francisco, California, USA.
Neil
N
Littman
California Institute for Regenerative Medicine, San Francisco, California, USA aabo@cirm.ca.gov.
Arie
A
Abo
D000818:Animals; D035843:Biomedical Research / Q000639:trends*; D001861:Bone Regeneration; D064987:Cell- and Tissue-Based Therapy; D006801:Humans; D010012:Osteogenesis; D013234:Stem Cells